Stocks and Investing
Stocks and Investing
Mon, August 14, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, August 11, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Swayampakula Ramakanth Reiterated (XFOR) at Strong Buy and Held Target at $3 on, Aug 11th, 2023
Swayampakula Ramakanth of HC Wainwright & Co., Reiterated "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy and Held Target at $3 on, Aug 11th, 2023.
Swayampakula has made no other calls on XFOR in the last 4 months.
There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Swayampakula's Rating of Hold.
This is the rating of the analyst that currently disagrees with Swayampakula
- Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $5 on, Wednesday, May 17th, 2023
Contributing Sources